294 related articles for article (PubMed ID: 35138004)
1. Variations within Toll-like receptor (TLR) and TLR signaling pathway-related genes and their synergistic effects on the risk of Guillain-Barré syndrome.
Dutta D; Nagappa M; Sreekumaran Nair BV; Das SK; Wahatule R; Sinha S; Vasanthapuram R; Taly AB; Debnath M
J Peripher Nerv Syst; 2022 Jun; 27(2):131-143. PubMed ID: 35138004
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 2 and -4 are involved in the pathogenesis of the Guillain-Barré syndrome.
Du Y; Zhang G; Zhang Z; Wang Q; Ma R; Zhang L; Fan F; Li Y; Wang M; Lv H; Kang X
Mol Med Rep; 2015 Aug; 12(2):3207-13. PubMed ID: 25954926
[TBL] [Abstract][Full Text] [Related]
3. The combination of maltose-binding protein and BCG-induced Th1 activation is involved in TLR2/9-mediated upregulation of MyD88-TRAF6 and TLR4-mediated downregulation of TRIF-TRAF3.
Liu G; Zhai X; Zhou H; Yang X; Zhang N; Tai G; Ni W
Cell Immunol; 2018 Mar; 325():56-63. PubMed ID: 29452695
[TBL] [Abstract][Full Text] [Related]
4. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
5. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
[TBL] [Abstract][Full Text] [Related]
6. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects.
Dasu MR; Devaraj S; Park S; Jialal I
Diabetes Care; 2010 Apr; 33(4):861-8. PubMed ID: 20067962
[TBL] [Abstract][Full Text] [Related]
7. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-beta (TRIF)-dependent pathway in TLR signaling.
Gohda J; Matsumura T; Inoue J
J Immunol; 2004 Sep; 173(5):2913-7. PubMed ID: 15322147
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
9. Association of TLR4 Asp299Gly and Thr399Ile polymorphisms with Guillain-Barré syndrome in Northern Indian population.
Nyati KK; Prasad KN; Verma A; Singh AK; Rizwan A; Sinha S; Paliwal VK; Pradhan S
J Neuroimmunol; 2010 Jan; 218(1-2):116-9. PubMed ID: 19913922
[TBL] [Abstract][Full Text] [Related]
10. Toll-like-Receptor Gene Polymorphisms in Tunisian Endemic Pemphigus Foliaceus.
Abida O; Bahloul E; Elloumi N; Toumi A; Tahri S; Ben Jmaa M; Fakhfakh R; Mahfoudh N; Turki H; Masmoudi H
Biomed Res Int; 2020; 2020():6541761. PubMed ID: 33204706
[TBL] [Abstract][Full Text] [Related]
11. Toll-like receptor-4 299Gly allele is associated with Guillain-Barré syndrome in Bangladesh.
Jahan I; Ahammad RU; Khalid MM; Rahman MI; Hayat S; Islam B; Mohammad QD; Islam Z
Ann Clin Transl Neurol; 2019 Apr; 6(4):708-715. PubMed ID: 31019995
[TBL] [Abstract][Full Text] [Related]
12. Remnant Cholesterol and Dyslipidemia Are Risk Factors for Guillain-Barré Syndrome and Severe Guillain-Barré Syndrome by Promoting Monocyte Activation.
Ding Y; Wang L; Sun J; Shi Y; Li G; Luan X; Zheng G; Zhang G
Front Immunol; 2022; 13():946825. PubMed ID: 35911688
[TBL] [Abstract][Full Text] [Related]
13. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
[TBL] [Abstract][Full Text] [Related]
14. Variants in the Toll-interacting protein gene are associated with susceptibility to sepsis in the Chinese Han population.
Song Z; Yin J; Yao C; Sun Z; Shao M; Zhang Y; Tao Z; Huang P; Tong C
Crit Care; 2011; 15(1):R12. PubMed ID: 21219635
[TBL] [Abstract][Full Text] [Related]
15. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex.
Youn HS; Lee JY; Fitzgerald KA; Young HA; Akira S; Hwang DH
J Immunol; 2005 Sep; 175(5):3339-46. PubMed ID: 16116226
[TBL] [Abstract][Full Text] [Related]
16. A role for the adaptor proteins TRAM and TRIF in toll-like receptor 2 signaling.
Nilsen NJ; Vladimer GI; Stenvik J; Orning MP; Zeid-Kilani MV; Bugge M; Bergstroem B; Conlon J; Husebye H; Hise AG; Fitzgerald KA; Espevik T; Lien E
J Biol Chem; 2015 Feb; 290(6):3209-22. PubMed ID: 25505250
[TBL] [Abstract][Full Text] [Related]
17. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer.
Etokebe GE; Knezević J; Petricević B; Pavelić J; Vrbanec D; Dembić Z
Genet Test Mol Biomarkers; 2009 Dec; 13(6):729-34. PubMed ID: 19810822
[TBL] [Abstract][Full Text] [Related]
18. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
Yamamoto M; Sato S; Mori K; Hoshino K; Takeuchi O; Takeda K; Akira S
J Immunol; 2002 Dec; 169(12):6668-72. PubMed ID: 12471095
[TBL] [Abstract][Full Text] [Related]
19. Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.
Wang YZ; Liang QH; Ramkalawan H; Wang YL; Yang YF; Zhou WB; Tian FF; Li J; Yang H
Neuroimmunomodulation; 2012; 19(1):60-8. PubMed ID: 22067623
[TBL] [Abstract][Full Text] [Related]
20. SAMe prevents the up regulation of toll-like receptor signaling in Mallory-Denk body forming hepatocytes.
Bardag-Gorce F; Oliva J; Lin A; Li J; French BA; French SW
Exp Mol Pathol; 2010 Jun; 88(3):376-9. PubMed ID: 20206621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
